Abstract
Objective
To describe a novel CONsolidated Standards of Reporting Trials (CONSORT) adherence
strategy implemented by the American Journal of Orthodontics and Dentofacial Orthopedics
(AJO-DO) and to report its impact on the completeness of reporting of published trials.
Study Design and Setting
The AJO-DO CONSORT adherence strategy, initiated in June 2011, involves active assessment
of randomized clinical trial (RCT) reporting during the editorial process. The completeness
of reporting CONSORT items was compared between trials submitted and published during
the implementation period (July 2011 to September 2013) and trials published between
August 2007 and July 2009.
Results
Of the 42 RCTs submitted (July 2011 to September 2013), 23 were considered for publication
and assessed for completeness of reporting, seven of which were eventually published.
For all published RCTs between 2007 and 2009 (n = 20), completeness of reporting by CONSORT item ranged from 0% to 100% (Median = 40%,
interquartile range = 60%). All published trials in 2011–2013, reported 33 of 37 CONSORT
(sub) items. Four CONSORT 2010 checklist items remained problematic even after implementation
of the adherence strategy: changes to methods (3b), changes to outcomes (6b) after
the trial commenced, interim analysis (7b), and trial stopping (14b), which are typically
only reported when applicable.
Conclusion
Trials published following implementation of the AJO-DO CONSORT adherence strategy
completely reported more CONSORT items than those published or submitted previously.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical EpidemiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.J Clin Epidemiol. 2010; 63: 834-840
- Does use of the CONSORT statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review.Syst Rev. 2012; 1: 60
- The reporting of randomized controlled trials in prosthodontics.Int J Prosth. 2002; 15: 230-242
- Control of bias in randomized controlled trials published in prosthodontic journals.J Prosth Dent. 2001; 86: 592-596
- Quality of RCTs in periodontology: a systematic review.J Dent Res. 2002; 81: 866-870
- Clinical trials in orthodontics II: assessment of the quality of reporting of clinical trials published in three orthodontic journals between 1989 and 1998.J Orthod. 2003; 30: 309-315
- The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist.Control Clin Trials. 2002; 23: 380-388
- An assessment of quality characteristics of randomised control trials published in dental journals.J Dent. 2010; 38: 713-721
- An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently.J Clin Epi. 2005; 58: 662-667
- Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed.J Clin Epi. 2011; 64: 136-144
- Systematic review of the empirical evidence of study publication bias and outcome reporting bias: an updated review.PLoS ONE. 2013; 8: e66844
- CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews.Am J Orthod Dentofacial Orthop. 2005; 128: 681-685
Article info
Publication history
Published online: May 14, 2014
Accepted:
April 9,
2014
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
